APEX-STROKE CALM-ICH Domain

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1100 participants.

Also called NCT07752719

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 1,100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07752719
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07752719. Randomized; quadruple masking; primary purpose treatment. Start 2026-10-01 (anticipated); primary completion 2029-01-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
APEX-STROKE CALM-ICH Domain
Acronym
CALM-ICH
Condition
Stroke
Condition
Intracerebral Hemorrhage
Intervention (Drug)
Angong Niuhuang Pills (ANP)
Intervention (Drug)
Placebo
Lead sponsor
Fudan University (class: other)
Collaborator
Huashan Hospital (class: other)
Collaborator
Chinese PLA General Hospital (class: other)
Collaborator
Beijing University of Chinese Medicine (class: other)
Collaborator
Hubei College of Traditional Chinese Medicine (class: other)
Collaborator
Guangdong Provincial Hospital of Traditional Chinese Medicine (class: other)

Record details

Record id
cardio:ct-nct07752719
Content hash
6e7262d65990d9d35a2dba1854358ca4897189ee5d9a5bce5f66433ae35e5363